InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Scholar Rock Holding Corp

SRRK Clue Score52
United States Fiscal year ends December CIK 0001727196 Results filed 6 Aug 2026
Add to watchlist

What the insiders did Balanced

Individual transactions

49
Insider
Date
Role
Action
Shares
Price
Amount
Mo Qatanani
14 Jan 2026
Chief Scientific Officer
Sold after exercise
13,112
$45.20
$592.61K
Mo Qatanani
4 Dec 2025
Chief Scientific Officer
Sold after exercise
136,462
$45.21
$6.17M
Jeffrey S. Flier
23 Jun 2025
Director
Sold after exercise indirect
11,136
$33.21
$369.82K
Jeffrey S. Flier
23 Jun 2025
Director
Sold after exercise
2,766
$32.74
$90.55K
Jeffrey S. Flier
23 Jun 2025
Director
Sold after exercise
17,550
$32.16
$564.36K
Tracey Sacco
25 Apr 2025
Chief Commercial Officer
Sold after exercise
84
$33.49
$2.81K
Tracey Sacco
25 Apr 2025
Chief Commercial Officer
Sold after exercise
4,916
$32.81
$161.32K
Erin Moore
24 Mar 2025
Interim PFO and PAO
Sold after exercise
13,564
$33.12
$449.24K
Tracey Sacco
24 Mar 2025
Chief Commercial Officer
Sold after exercise
5,000
$32.89
$164.46K
Tracey Sacco
24 Mar 2025
Chief Commercial Officer
Sold after exercise
1,500
$33.70
$50.56K
Edward H Myles
10 Mar 2025
COO & CFO
Sold after exercise
29,395
$34.87
$1.03M
Edward H Myles
10 Mar 2025
COO & CFO
Sold after exercise
112,897
$35.82
$4.04M
Mo Qatanani
19 Feb 2025
Chief Scientific Officer
Sold after exercise
20,202
$37.74
$762.50K
Mo Qatanani
19 Feb 2025
Chief Scientific Officer
Sold after exercise
8,341
$37.56
$313.29K
Mo Qatanani
19 Feb 2025
Chief Scientific Officer
Sold after exercise
39,967
$37.20
$1.49M
Jing L. Marantz
25 Nov 2024
Chief Medical Officer
Sold after exercise
200
$40.72
$8.14K
Jing L. Marantz
25 Nov 2024
Chief Medical Officer
Sold after exercise
3,075
$39.93
$122.78K
Jing L. Marantz
25 Nov 2024
Chief Medical Officer
Sold after exercise
2,100
$39.25
$82.43K
Jing L. Marantz
25 Nov 2024
Chief Medical Officer
Sold after exercise
1,000
$38.04
$38.04K
Jing L. Marantz
22 Nov 2024
Chief Medical Officer
Sold after exercise
2,145
$30.01
$64.37K
Jing L. Marantz
11 Nov 2024
Chief Medical Officer
Sold after exercise
2,105
$30.00
$63.16K
Edward H Myles
8 Oct 2024
COO & CFO
Sold after exercise
37,187
$34.90
$1.30M
Jing L. Marantz
7 Oct 2024
Chief Medical Officer
Sold after exercise
39,375
$30.06
$1.18M
Jing L. Marantz
7 Oct 2024
Chief Medical Officer
Sold after exercise
2,552
$26.22
$66.92K
Jing L. Marantz
7 Oct 2024
Chief Medical Officer
Sold after exercise
67,448
$25.59
$1.73M
Tracey Sacco
7 Oct 2024
Chief Commercial Officer
Sold after exercise
1,964
$26.23
$51.52K
Tracey Sacco
7 Oct 2024
Chief Commercial Officer
Sold after exercise
28,036
$25.58
$717.16K
Edward H Myles
7 Oct 2024
COO & CFO
Sold after exercise
31,250
$29.05
$907.81K
Edward H Myles
7 Oct 2024
COO & CFO
Sold after exercise
25,812
$27.27
$703.89K
Edward H Myles
7 Oct 2024
COO & CFO
Sold after exercise
37,206
$26.83
$998.24K
Edward H Myles
7 Oct 2024
COO & CFO
Sold after exercise
111,972
$25.61
$2.87M
Edward H Myles
29 Dec 2023
COO & CFO
Sold after exercise
300
$19.51
$5.85K
Edward H Myles
29 Dec 2023
COO & CFO
Sold after exercise
12,159
$18.82
$228.78K
Mo Qatanani
14 Dec 2023
SVP and Head of Research
Sold after exercise
24,662
$18.18
$448.44K
Edward H Myles
7 Dec 2023
COO & CFO
Sold after exercise
24,914
$17.53
$436.82K
Edward H Myles
15 Nov 2021
Chief Financial Officer
Sold after exercise
4,879
$35.05
$171.01K
Edward H Myles
12 Nov 2021
Chief Financial Officer
Sold after exercise
49,848
$35.12
$1.75M
Edward H Myles
11 Nov 2021
Chief Financial Officer
Sold after exercise
23,574
$35.20
$829.86K
Gregory John Carven
27 Jan 2021
Head of Research
Sold after exercise
1,561
$57.79
$90.21K
Gregory John Carven
27 Jan 2021
Head of Research
Sold after exercise
12,139
$56.72
$688.51K
Gregory John Carven
27 Jan 2021
Head of Research
Sold after exercise
5,400
$55.87
$301.68K
Gregory John Carven
26 Jan 2021
Head of Research
Sold after exercise
1,064
$61.52
$65.45K
Gregory John Carven
26 Jan 2021
Head of Research
Sold after exercise
8,417
$60.65
$510.49K
Gregory John Carven
26 Jan 2021
Head of Research
Sold after exercise
9,249
$59.69
$552.10K
Gregory John Carven
26 Jan 2021
Head of Research
Sold after exercise
13,368
$58.79
$785.97K
Gregory John Carven
26 Jan 2021
Head of Research
Sold after exercise
4,676
$57.91
$270.81K
Michael Gilman
26 Jan 2021
Director
Sold after exercise
1,518
$59.90
$90.93K
Michael Gilman
26 Jan 2021
Director
Sold after exercise
1,500
$59.02
$88.53K
Michael Gilman
26 Jan 2021
Director
Sold after exercise
483
$57.99
$28.01K
Show all 194 transactions →

What was left out

Form 4 filings counted 282
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 13
Sales on a Rule 10b5-1 plan 44
Sales straight out of an exercise 49
Sales at will 63
Transactions with no price 0
Shares from compensation/vesting 30,452,736
Sales filed before the plan box existed 7
History held since 31 May 2018